Compare MGTX & CPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGTX | CPF |
|---|---|---|
| Founded | 2015 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 909.1M | 880.7M |
| IPO Year | 2018 | 2011 |
| Metric | MGTX | CPF |
|---|---|---|
| Price | $9.00 | $35.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $24.57 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 686.1K | 96.6K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | 33.02 | ★ 45.18 |
| EPS | N/A | ★ 0.78 |
| Revenue | ★ $81,391,000.00 | $51,817,000.00 |
| Revenue This Year | $141.38 | N/A |
| Revenue Next Year | N/A | $4.62 |
| P/E Ratio | ★ N/A | $44.59 |
| Revenue Growth | ★ 144.57 | 33.81 |
| 52 Week Low | $6.03 | $25.62 |
| 52 Week High | $11.85 | $35.45 |
| Indicator | MGTX | CPF |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 57.72 |
| Support Level | $8.82 | $33.25 |
| Resistance Level | $9.65 | N/A |
| Average True Range (ATR) | 0.48 | 0.77 |
| MACD | -0.08 | -0.01 |
| Stochastic Oscillator | 5.73 | 88.54 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services. It operates in single segment which is Banking operations.